RNU6-1092P

Across TCGA pan-cancer cohorts, RNU6-1092P RNA is linked to patient survival in 11 of 34 cancer types, making it the most broadly survival-associated RNU6-1092P data layer.

The strongest signal is observed in uveal melanoma (UVM), where higher RNU6-1092P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU6-1092P expression acts as an unfavorable survival marker, although some lineages such as BLCA and STAD show a favorable association.

UVM, BLCA, and READ are the cancer types where RNU6-1092P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UVM	OS	Tertile	All	0.104	0.858	<.001	99	view →
BLCA	DFS	Tertile	III,IV	0.648	0.276	.012	78	view →
READ	DFS	Tertile	All	0.255	0.844	.004	63	view →
STAD	OS	Tertile	II,III,IV	0.695	0.493	.009	54	view →
CESC	OS	Tertile	IV	0.149	0.614	.002	36	view →
OV	DFS	Tertile	IV	0.163	0.475	.006	36	view →
CHOL	OS	Tertile	All	0.154	0.793	.004	27	view →
LIHC	DFS	Tertile	All	0.076	0.557	<.001	27	view →
ESCA	OS	Quartile	All	0.444	0.601	.024	9	view →
THYM	OS	Tertile	All	0.734	0.971	.020	6	view →
LAML	DFS	Median	All	0.480	0.667	.039	6	view →

Pink = unfavorable, green = favorable. Showing the 11 strongest of 11 lineages.

RNU6-1092P–UVM (OS)

Open the UVM breakdown →